| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,522 | 15,649 | 15,471 | 15,602 | | Cost of Revenue | 3,538 | 4,099 | 4,179 | 4,539 | | | Gross Profit |
-
| 11,551 | 11,292 | 11,063 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,408 | 6,378 | 5,888 | 5,885 | | Non Recurring | (74) | (5) | 80 |
-
| | Others | 1,382 | 1,835 | 1,634 | 1,333 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 3,343 | 3,690 | 3,846 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,268 | 3,343 | 3,690 | 3,846 | | Interest Expense | 384 | 448 | 450 | 539 | | Income Before Tax | 2,884 | 2,895 | 3,240 | 3,307 | | Income Tax Expense | 1,123 | 1,135 | 1,236 | 1,287 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,762 | 1,760 | 2,005 | 2,019 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,762 | 1,760 | 2,005 | 2,019 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,762 | $1,760 | $2,005 | $2,019 |
|
0.26% Nasdaq 0.00%
Income Statement
